{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:23:29Z","timestamp":1790702609861,"version":"4.1.0"},"reference-count":112,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,9,27]]},"DOI":"10.18632\/aging.102328","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T12:21:05Z","timestamp":1569586865000},"page":"8433-8462","source":"Crossref","is-referenced-by-count":50,"title":["Brain pyrimidine nucleotide synthesis and Alzheimer disease"],"prefix":"10.18632","volume":"11","author":[{"given":"Alba","family":"Pesini","sequence":"first","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldris","family":"Iglesias","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Pilar","family":"Bayona-Bafaluy","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Garrido-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Meade","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gaud\u00f3","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Jim\u00e9nez-Salvador","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Andr\u00e9s-Benito","sequence":"additional","affiliation":[{"name":"Departamento de Patolog\u00eda y Terap\u00e9utica Experimental, Universidad de Barcelona, Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Montoya","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Departamento de Patolog\u00eda y Terap\u00e9utica Experimental, Universidad de Barcelona, Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Servicio de Anatom\u00eda Patol\u00f3gica, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Instituto de Neurociencias, Universidad de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Pesini","sequence":"additional","affiliation":[{"name":"Araclon Biotech, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ruiz-Pesini","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica, Biolog\u00eda Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Arag\u00f3n (IIS Arag\u00f3n), Zaragoza, Spain"},{"name":"Centro de Investigaciones Biom\u00e9dicas en Red de Enfermedades Raras (CIBERER), Madrid, Spain"},{"name":"Fundaci\u00f3n ARAID, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis.","volume":"25","author":"Higgins","year":"1992","journal-title":"Science"},{"key":"2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease.","volume":"6","author":"Khan","year":"2004","journal-title":"Med Hypotheses"},{"key":"3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.brainresbull.2016.08.009","article-title":"Amyloid precursor protein processing and bioenergetics.","volume":"13","author":"Swerdlow","year":"2017","journal-title":"Brain Res Bull"},{"key":"4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/187569211795508457","article-title":"Mitogenomics: recognizing the significance of mitochondrial genomic variation for personalized medicine.","volume":"9","author":"Ruiz-Pesini","year":"2011","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"33035","DOI":"10.1074\/jbc.R400007200","article-title":"Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway.","volume":"27","author":"Guy","year":"2004","journal-title":"J Biol Chem"},{"key":"6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.copbio.2017.03.010","article-title":"Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.","volume":"4","author":"Bassik","year":"2017","journal-title":"Curr Opin Biotechnol"},{"key":"7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn2593","article-title":"Plasma membrane expansion: a neuron\u2019s Herculean task.","volume":"1","author":"Pfenninger","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons.","volume":"2","author":"Trudeau","year":"2015","journal-title":"Curr Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3233\/JAD-140384","article-title":"OXPHOS, pyrimidine nucleotides, and Alzheimer\u2019s disease: a pharmacogenomics approach.","volume":"4","author":"Ruiz-Pesini","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure.","volume":"29","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/15257770.2015.1124998","article-title":"Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines.","volume":"3","author":"van Kuilenburg","year":"2016","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2018.01.107","article-title":"Leflunomide: A promising drug with good antitumor potential.","volume":"49","author":"Chu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1593\/neo.10168","article-title":"Teriflunomide (leflunomide) promotes cytostatic, antioxidant, and apoptotic effects in transformed prostate epithelial cells: evidence supporting a role for teriflunomide in prostate cancer chemoprevention.","volume":"1","author":"Bushman","year":"2010","journal-title":"Neoplasia"},{"key":"14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0006-2952(95)00255-X","article-title":"Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.","volume":"5","author":"Lou","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1567-7249(02)00045-4","article-title":"Mechanism of leflunomide-induced proliferation of mitochondria in mammalian cells.","volume":"2","author":"Wakabayashi","year":"2002","journal-title":"Mitochondrion"},{"key":"16","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0891-5849(00)00239-2","article-title":"Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide.","volume":"2","author":"Lepoivre","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2010.04.006","article-title":"Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.","volume":"4","author":"Shearn","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"12308","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.","volume":"7","author":"McKenna","year":"2016","journal-title":"Nat Commun"},{"key":"19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2131\/jts.41.605","article-title":"Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.","volume":"4","author":"Sugai","year":"2016","journal-title":"J Toxicol Sci"},{"key":"20","doi-asserted-by":"publisher","first-page":"eaao5563","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.","volume":"1","author":"Pignolet","year":"2019","journal-title":"Sci Transl Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1042\/BSR20120097","article-title":"Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction.","volume":"3","author":"Kang","year":"2013","journal-title":"Biosci Rep"},{"key":"22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/eos.12270","article-title":"Dihydroorotate dehydrogenase depletion hampers mitochondrial function and osteogenic differentiation in osteoblasts.","volume":"12","author":"Nonaka","year":"2016","journal-title":"Eur J Oral Sci"},{"key":"23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2050-6511-15-27","article-title":"Uridine prevents tamoxifen-induced liver lipid droplet accumulation.","volume":"1","author":"Pizzorno","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1006859115450","article-title":"Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides.","volume":"17","author":"Becker","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"25","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/s41467-018-04603-z","article-title":"Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints.","volume":"9","author":"Caisova","year":"2018","journal-title":"Nat Commun"},{"key":"26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2005.10.056","article-title":"Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.","volume":"106","author":"Saydoff","year":"2005","journal-title":"Brain Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JAD-130059","article-title":"Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer\u2019s disease in related models.","volume":"3","author":"von Borstel","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1385\/JMN:27:1:137","article-title":"Dietary uridine-5\u2032-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats.","volume":"2","author":"Wurtman","year":"2005","journal-title":"J Mol Neurosci"},{"key":"29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/1097-4547(20000715)61:2<206::AID-JNR11>3.0.CO;2-B","article-title":"Uridine induces differentiation in human neuroblastoma cells via protein kinase C epsilon.","volume":"6","author":"Lauro","year":"2000","journal-title":"J Neurosci Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroscience.2005.03.050","article-title":"Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected].","volume":"13","author":"Wurtman","year":"2005","journal-title":"Neuroscience"},{"key":"31","doi-asserted-by":"publisher","first-page":"e0143004","DOI":"10.1371\/journal.pone.0143004","article-title":"Uridine from Pleurotus giganteus and its neurite outgrowth stimulatory effects with underlying mechanism.","volume":"1","author":"Sabaratnam","year":"2015","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1039\/C4CS00038B","article-title":"O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer\u2019s disease and beyond.","volume":"4","author":"Vocadlo","year":"2014","journal-title":"Chem Soc Rev"},{"key":"33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cbpa.2016.06.005","article-title":"Nutrient regulation of gene expression by O-GlcNAcylation of chromatin.","volume":"3","author":"Hart","year":"2016","journal-title":"Curr Opin Chem Biol"},{"key":"34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions.","volume":"1","author":"Qian","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/14728222.2018.1536748","article-title":"The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia.","volume":"2","author":"Sykes","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/15257770.2018.1453076","article-title":"New perspectives on the roles of pyrimidines in the central nervous system.","volume":"3","author":"Zameitat","year":"2018","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"37","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/15257770.2011.603712","article-title":"Gene expression of enzymes required for the de novo synthesis and degradation of pyrimidines in rat peripheral tissues and brain.","volume":"3","author":"Sch\u00e4fer","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/15257771003730128","article-title":"Region-specific distribution of dihydroorotate dehydrogenase in the rat central nervous system points to pyrimidine de novo synthesis in neurons.","volume":"2","author":"L\u00f6fflerr","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3181\/00379727-100-24663","article-title":"Incorporation of L-carbamyl-C14-aspartate into acid-soluble pyrimidine nucleotides of mouse brain.","volume":"10","author":"Pearson","year":"1959","journal-title":"Proc Soc Exp Biol Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1471-4159.1963.tb08927.x","article-title":"Studies of pyrimidine nucleotide metabolism in the central nervous system-I. Metabolic effects and metabolism of 6-Azauridine.","volume":"1","author":"Koenig","year":"1963","journal-title":"J Neurochem"},{"key":"41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1471-4159.1965.tb10262.x","article-title":"Some observations on the incorporation of precursors into ribonucleic acid of rat brain.","volume":"1","author":"Adams","year":"1965","journal-title":"J Neurochem"},{"key":"42","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/j.1471-4159.1971.tb03744.x","article-title":"Studies on the origin of pyrimidines for biosynthesis of neural RNA in the rat.","volume":"1","author":"Udenfriend","year":"1971","journal-title":"J Neurochem"},{"key":"43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1471-4159.1972.tb06207.x","article-title":"Pyrimidine biosynthesis in rat brain.","volume":"1","author":"Tremblay","year":"1972","journal-title":"J Neurochem"},{"key":"44","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/978-3-642-85448-4_337","article-title":"[Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].","volume":"7","author":"Decker","year":"1972","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"45","first-page":"57","article-title":"Pyrimidine biosynthesis and its regulation in the developing rat brain.","volume":"2","author":"Crandall","year":"1976","journal-title":"J Neurochem"},{"key":"46","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0006-2952(78)90501-4","article-title":"Inhibition by barbituric acid and its derivatives of the enzymes in rat brain which participate in the synthesis of pyrimidine ribotides.","volume":"2","author":"Krooth","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1042\/bj1720457","article-title":"The influence of ammonia on purine and pyrimidine nucleotide biosynthesis in rat liver and brain in vitro.","volume":"17","author":"Schafer","year":"1978","journal-title":"Biochem J"},{"key":"48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/978-1-4684-4553-4_102","article-title":"Pyrimidine metabolism in rat brain cortex and liver.","volume":"16","author":"Veerkamp","year":"1984","journal-title":"Adv Exp Med Biol"},{"key":"49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0003-9861(73)90651-6","article-title":"Distribution, subcellular localization, and product inhibition of dihydroorotate oxidation in the rat.","volume":"15","author":"Kennedy","year":"1973","journal-title":"Arch Biochem Biophys"},{"key":"50","first-page":"211","article-title":"[Modification of kidney function by orotic acid in acute and chronic administration].","volume":"3","author":"Matthies","year":"1974","journal-title":"Acta Biol Med Ger"},{"key":"51","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1530\/rep.0.1230757","article-title":"Detection and location of the enzymes of de novo pyrimidine biosynthesis in mammalian spermatozoa.","volume":"12","author":"Watson","year":"2002","journal-title":"Reproduction"},{"key":"52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"8","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"53","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2174\/15672050113106660166","article-title":"Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer\u2019s disease.","volume":"1","author":"Riederer","year":"2013","journal-title":"Curr Alzheimer Res"},{"key":"54","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.","volume":"7","author":"Del Tredici","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"55","doi-asserted-by":"publisher","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid.","volume":"7","author":"Senn","year":"2012","journal-title":"PLoS One"},{"key":"56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-131892","article-title":"Differences in nutritional status between very mild Alzheimer\u2019s disease patients and healthy controls.","volume":"4","author":"Scheltens","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"57","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1021\/pr5000895","article-title":"Plasma metabolite profiles of Alzheimer\u2019s disease and mild cognitive impairment.","volume":"1","author":"Zhao","year":"2014","journal-title":"J Proteome Res"},{"key":"58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.dadm.2017.04.005","article-title":"Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer\u2019s disease dementia.","volume":"8","author":"Teunissen","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"59","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/dneu.22716","article-title":"Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer\u2019s disease.","volume":"7","author":"Mapstone","year":"2019","journal-title":"Dev Neurobiol"},{"key":"60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/00002826-199008000-00002","article-title":"Memory deficits of aged male rats can be improved by pyrimidine nucleosides and n-acetyl-glutamine.","volume":"1","author":"Freni","year":"1990","journal-title":"Clin Neuropharmacol"},{"key":"61","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/jn\/136.11.2834","article-title":"Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats.","volume":"13","author":"Wurtman","year":"2006","journal-title":"J Nutr"},{"key":"62","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1096\/fj.08-112425","article-title":"Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils.","volume":"2","author":"Wurtman","year":"2008","journal-title":"FASEB J"},{"key":"63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainres.2017.01.026","article-title":"Long-term cognitive effects of uridine treatment in a neonatal rat model of hypoxic-ischemic encephalopathy.","volume":"165","author":"Kahveci","year":"2017","journal-title":"Brain Res"},{"key":"64","doi-asserted-by":"publisher","first-page":"e86558","DOI":"10.1371\/journal.pone.0086558","article-title":"The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer\u2019s disease: a randomised controlled study.","volume":"9","author":"van Straaten","year":"2014","journal-title":"PLoS One"},{"key":"65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1179\/0001551213Z.0000000006","article-title":"Rationale and clinical data supporting nutritional intervention in Alzheimer\u2019s disease.","volume":"6","author":"Vandewoude","year":"2014","journal-title":"Acta Clin Belg"},{"key":"66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12603-013-0411-2","article-title":"Souvenaid\u00ae: a new approach to management of early Alzheimer\u2019s disease.","volume":"1","author":"Passmore","year":"2014","journal-title":"J Nutr Health Aging"},{"key":"67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000369811","article-title":"Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study.","volume":"1","author":"Emberti Gialloreti","year":"2015","journal-title":"Neurodegener Dis"},{"key":"68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-015-0134-1","article-title":"Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer\u2019s disease.","volume":"7","author":"Olde Rikkert","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"69","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3233\/JAD-160745","article-title":"Effect size analyses of Souvenaid in patients with Alzheimer\u2019s disease.","volume":"5","author":"Shah","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"70","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","article-title":"Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing.","volume":"3","author":"Attwell","year":"2012","journal-title":"J Neurosci"},{"key":"71","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1432-1033.1990.tb15331.x","article-title":"Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine.","volume":"18","author":"Cantatore","year":"1990","journal-title":"Eur J Biochem"},{"key":"72","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1471-4159.2004.02884.x","article-title":"Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging.","volume":"9","author":"Reddy","year":"2005","journal-title":"J Neurochem"},{"key":"73","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0169-328X(94)90147-3","article-title":"Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.","volume":"2","author":"Rapoport","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"74","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00005072-199409000-00010","article-title":"Functional alterations in Alzheimer\u2019s disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation.","volume":"5","author":"Hyman","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0197-4580(95)00034-C","article-title":"Functional alterations in neural circuits in Alzheimer\u2019s disease.","volume":"1","author":"Hyman","year":"1995","journal-title":"Neurobiol Aging"},{"key":"76","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.410400310","article-title":"Neuronal activity and early neurofibrillary tangles in Alzheimer\u2019s disease.","volume":"4","author":"Chandrasekaran","year":"1996","journal-title":"Ann Neurol"},{"key":"77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0169-328X(96)00191-X","article-title":"Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease.","volume":"4","author":"Brady","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0006-8993(98)00248-0","article-title":"Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex.","volume":"79","author":"Rapoport","year":"1998","journal-title":"Brain Res"},{"key":"79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0169-328X(98)00117-X","article-title":"No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism.","volume":"5","author":"Rapoport","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"80","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1023\/A:1020783614031","article-title":"The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer\u2019s disease.","volume":"2","author":"Markesbery","year":"1999","journal-title":"Neurochem Res"},{"key":"81","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-142937","article-title":"Postmortem Alzheimer\u2019s disease hippocampi show oxidative phosphorylation gene expression opposite that of isolated pyramidal neurons.","volume":"4","author":"Bennett","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"82","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jalz.2016.09.003","article-title":"Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer\u2019s disease.","volume":"1","author":"Coleman","year":"2017","journal-title":"Alzheimers Dement"},{"key":"83","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer\u2019s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.","volume":"10","author":"Hulette","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"84","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.neurobiolaging.2014.03.031","article-title":"Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer\u2019s disease.","volume":"3","author":"Cotman","year":"2014","journal-title":"Neurobiol Aging"},{"key":"85","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2174\/1567205014666170505095921","article-title":"Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer\u2019s disease.","volume":"1","author":"Ferrer","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"86","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1038\/s41386-018-0144-3","article-title":"Genetic association of the cytochrome c oxidase-related genes with Alzheimer\u2019s disease in Han Chinese.","volume":"4","author":"Yao","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"87","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer\u2019s disease.","volume":"5","author":"Nobrega","year":"1992","journal-title":"J Neurochem"},{"key":"88","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00839971","article-title":"Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer\u2019s disease.","volume":"24","author":"Riederer","year":"1993","journal-title":"J Neurol"},{"key":"89","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/00005072-199311000-00004","article-title":"Functional alterations in Alzheimer\u2019s disease: diminution of cytochrome oxidase in the hippocampal formation.","volume":"5","author":"Hyman","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"90","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","article-title":"Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease.","volume":"6","author":"Beal","year":"1994","journal-title":"J Neurochem"},{"key":"91","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1212\/WNL.44.6.1090","article-title":"Electron transport chain defects in Alzheimer\u2019s disease brain.","volume":"4","author":"Kleinschmidt-DeMasters","year":"1994","journal-title":"Neurology"},{"key":"92","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/00001756-199503270-00002","article-title":"Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases.","volume":"6","author":"Gauvreau","year":"1995","journal-title":"Neuroreport"},{"key":"93","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1212\/WNL.45.7.1423","article-title":"Cytochrome c oxidase in Alzheimer\u2019s disease.","volume":"4","author":"Jerusalem","year":"1995","journal-title":"Neurology"},{"key":"94","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0006-8993(96)01464-3","article-title":"Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer\u2019s patients.","volume":"75","author":"Matos-Collazo","year":"1997","journal-title":"Brain Res"},{"key":"95","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0306-4522(96)00410-1","article-title":"Brain cytochrome oxidase subunit complementary DNAs: isolation, subcloning, sequencing, light and electron microscopic in situ hybridization of transcripts, and regulation by neuronal activity.","volume":"7","author":"Guyer","year":"1997","journal-title":"Neuroscience"},{"key":"96","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1046\/j.1471-4159.1999.0720700.x","article-title":"Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer\u2019s disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?","volume":"7","author":"Chang","year":"1999","journal-title":"J Neurochem"},{"key":"97","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s004010050997","article-title":"Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology.","volume":"9","author":"Matthews","year":"1999","journal-title":"Acta Neuropathol"},{"key":"98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0047-6374(99)00071-8","article-title":"Mitochondrial respiratory chain activity in the human brain as a function of age.","volume":"11","author":"Byrne","year":"1999","journal-title":"Mech Ageing Dev"},{"key":"99","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0197-4580(00)00112-3","article-title":"A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.","volume":"2","author":"M\u00f6ller","year":"2000","journal-title":"Neurobiol Aging"},{"key":"100","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1006\/exnr.2000.7385","article-title":"Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits.","volume":"16","author":"Swaab","year":"2000","journal-title":"Exp Neurol"},{"key":"101","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0197-4580(00)00234-7","article-title":"Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age.","volume":"2","author":"Turnbull","year":"2001","journal-title":"Neurobiol Aging"},{"key":"102","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1523\/JNEUROSCI.21-13-04923.2001","article-title":"Energy hypometabolism in posterior cingulate cortex of Alzheimer\u2019s patients: superficial laminar cytochrome oxidase associated with disease duration.","volume":"2","author":"Gonzalez-Lima","year":"2001","journal-title":"J Neurosci"},{"key":"103","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","article-title":"Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer\u2019s disease.","volume":"2","author":"Solaini","year":"2002","journal-title":"Neurobiol Aging"},{"key":"104","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer\u2019s disease brain is associated with mitochondrial dysfunction.","volume":"2","author":"Anandatheerthavarada","year":"2006","journal-title":"J Neurosci"},{"key":"105","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00401-008-0370-6","article-title":"Dystrophic neurites of senile plaques in Alzheimer\u2019s disease are deficient in cytochrome c oxidase.","volume":"11","author":"Ferrer","year":"2008","journal-title":"Acta Neuropathol"},{"key":"106","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-2011-101716","article-title":"Decreased proteolytic activity of the mitochondrial amyloid-\u03b2 degrading enzyme, PreP peptidasome, in Alzheimer\u2019s disease brain mitochondria.","volume":"2","author":"Yan","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"107","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3233\/JAD-2012-120283","article-title":"New evidence of mitochondria dysfunction in the female Alzheimer\u2019s disease brain: deficiency of estrogen receptor-\u03b2.","volume":"3","author":"Li","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"108","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41386-018-0090-0","article-title":"Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.","volume":"4","author":"Mann","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"109","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/BF03033178","article-title":"Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.","volume":"5","author":"Joyce","year":"2004","journal-title":"Neurotox Res"},{"key":"110","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bpa.12474","article-title":"Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson\u2019s disease and Parkinson\u2019s disease with dementia.","volume":"2","author":"Ferrer","year":"2018","journal-title":"Brain Pathol"},{"key":"111","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1021\/ac9806005","article-title":"Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification.","volume":"7","author":"Chait","year":"1998","journal-title":"Anal Chem"},{"key":"112","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.","volume":"2","author":"MacCoss","year":"2010","journal-title":"Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T15:22:50Z","timestamp":1599060170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":112,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019,10,15]]}},"alternative-id":["102328","31560653"],"URL":"https:\/\/doi.org\/10.18632\/aging.102328","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}